/ / Approval 
Biomedical IRB 
University of Pittsburgh 
Page 1 
CONSENT TO ACT AS A SUBJECT IN AN EXPERIMENTAL STUDY 
TITLE : EL- 12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts 
(94-21). 
PRINCIPAL INVESTIGATORS: Hideaki Tahara, M.D., Ph.D. 
Research Assistant Professor of Surgery 
University of Pittsburgh 
School of Medicine 
Pittsburgh, PA 15261 
(412) 648-9489 
Michael T. Lotze, M.D. 
Director of Surgical Oncology 
Pittsburgh Cancer Institute 
Professor of Surgery 
University of Pittsburgh 
School of Medicine 
Pittsburgh, PA 15261 
(412) 648-9489 
CO-DSfVESTIGATORS : Paul D. Robbins, Ph.D. 
Assistant Professor 
Molecular Genetics and Biochemistry 
University of Pittsburgh 
School of Medicine 
(412) 648-9268 
Walter J. Storkus, Ph.D. 
Assistant Professor of Surgery 
Molecular Genetics and Biochemistry 
University of Pittsburgh 
School of Medicine 
(412) 624-9375 
Laurence Zitvogel, M.D. 
Research Fellow 
Molecular Genetics and Biochemistry 
University of Pittsburgh 
School of Medicine 
(412) 624-9375 
Howard Edington, M.D. 
Assistant Professor of Surgery 
668 Scaife Hall 
(412) 648-9489 
Jeffrey Myers, M.D., Ph.D. 
Research Fellow 
Recombinant DNA Research, Volume 19 
Patient's Initials 
[665] 
